| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Novel small-molecule inhibitors of the SARS-CoV-2 spike protein binding to neuropilin 1
Authors:ID Kolarič, Anja (Author)
ID Jukič, Marko (Author)
ID Bren, Urban (Author)
Files:.pdf pharmaceuticals-15-00165-v2.pdf (6,27 MB)
MD5: B82CA77FA0906A8506807CA8247AE1BD
 
URL https://www.mdpi.com/1424-8247/15/2/165
 
Language:English
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FKKT - Faculty of Chemistry and Chemical Engineering
Abstract:Furin cleavage of the SARS-CoV-2 spike protein results in a polybasic terminal sequence termed the C-end rule (CendR), which is responsible for the binding to neuropilin 1 (NRP1), enhancing viral infectivity and entry into the cell. Here we report the identification of 20 small-molecule inhibitors that emerged from a virtual screening of nearly 950,000 drug-like compounds that bind with high probability to the CendR-binding pocket of NRP1. In a spike NRP1 binding assay, two of these compounds displayed a stronger inhibition of spike protein binding to NRP1 than the known NRP1 antagonist EG00229, for which the inhibition of the CendR peptide binding to NRP1 was also experimentally confirmed. These compounds present a good starting point for the design of small-molecule antagonists against the SARS-CoV-2 viral entry.
Keywords:neuropilin 1, SARS-CoV-2, COVID-19, spike binding inhibitors, virtual screening, small-molecule antagonists, molecular docking, in vitro binding assay
Publication status:Published
Publication version:Version of Record
Submitted for review:29.10.2021
Article acceptance date:26.01.2022
Publication date:28.01.2022
Publisher:MDPI, Molecular Diversity Preservation International
Year of publishing:2022
Number of pages:14 str.
Numbering:Vol. 15, no. 2
PID:20.500.12556/DKUM-92745 New window
UDC:577
ISSN on article:1424-8247
COBISS.SI-ID:95574275 New window
DOI:10.3390/ph15020165 New window
Copyright:© 2022 by the authors
Publication date in DKUM:09.05.2025
Views:166
Downloads:16
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Pharmaceuticals
Shortened title:Pharmaceuticals
Publisher:MDPI, Molecular Diversity Preservation International
ISSN:1424-8247
COBISS.SI-ID:517582617 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0046-2019
Name:Separacijski procesi in produktna tehnika

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-2471-2020
Name:Kemijska karcinogeneza: Mehanistični vpogled

Funder:the Slovenian Ministry of Education, Science and Sports
Project number:OP20.04342

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:inhibitorji, molekule


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica